Control of CCI-779 dosage form stability through control of drug substance impurities

Details for Australian Patent Application No. 2006331874 (hide)

Owner Wyeth

Inventors Rubino, Joseph Thomas; Pooja, Gandhi; Phelan, Lynn

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006331874

PCT Pub. Number WO2007/075621

Priority 60/752,189 20.12.05 US

Filing date 19 December 2006

Wipo publication date 5 July 2007

International Classifications

A61K 31/05 (2006.01)

A61K 31/355 (2006.01)

A61K 31/375 (2006.01) - Ascorbic acid, i.e. vitamin C

A61K 31/436 (2006.01)

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/075621 Priority application(s): WO2007/075621

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331879-Immunostimulatory activity of palindromic immune modulatory oligonucleotides (IMO TM) contiaining different lengths of palindromic segments

2006331866-Candle and luminary light show